A Multi-country, Non-interventional, Retrospective Drug Utilization Study in Haematological Malignancy Patients Treated for Probable or Proven Invasive Aspergillosis (AmBiVor)

First published 17/05/2023

Last updated 22/04/2025

EU PAS number:

EUPAS104818

Study

Finalised

Documents

Study protocol

Initial protocol

GS-EU-131-6385 - appendix-16.1.-protocol_f-redact_reduced

English (5.25 MB - PDF) View document

Study results

Study report

GS-EU-131-6385 CSR Abstract

English (577.61 KB - PDF) View document

Other information

Secondary tabs